Conclusion
Studies on COVID-19 in children are vital to better understand their
unique epidemiological trends, clinical course, laboratory and
radiological findings, and prognosis and outcomes. Significant
differences exist in all these factors compared to adults. To date, data
in children is heavily skewed toward cases from China, and more data is
needed from a wider geographic area. This will better prepare us as the
cases rise and the dynamics of the pandemic continue to evolve. Emerging
information on the proportion of asymptomatic cases and its eventual
effect on spread of disease will benefit healthcare providers and public
health officers to design appropriate policies, especially with the
impending re-opening of schools.